News Releases

September 10, 2021

Aberdeen International Inc. (TSX: AAB, FR: A8H, OTC: AABVF) Reports 2021 Q2 Results with Net Income of $0.08 per Share Representing 300% Quarter-over-Quarter Growth and 167% Year-over-Year Growth

▪   Total revenue of $11.6 million, including net gain on investments of $11.5 million for the three months ended July 31, 2021 ▪   Net income for the three months ended July 31, 2021 was $10.9 million or $0.08 per basic share ▪   As at July 31, 2021, Aberdeen’s shareholders’ equity and net asset value (NAV) were $51.9 million, or $0.38 per basic share. On a quarter-over-quarter basis, Aberdeen’s shareholders’ equity has increased by $10.9 million, representing an approximate 27% increase. Given the nature of Aberdeen’s operations, there is currently no difference between “shareholder equity” and “net asset value” for Aberdeen […]
September 9, 2021

Aberdeen Investee, AES-100 Inc., Reports Technical Viability of Hydrogen Extraction from Natural Gas Pipelines using The Advanced Electrolyzer System Technology

Toronto, Canada – September 9, 2021 – Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB) (F: A8H) (OTC: AABVF) is pleased to announce that the team at AES-100 Inc. (“AES-100”), a 41.67% subsidiary of the Company, have now demonstrated results in the new and critical area of hydrogen recovery from natural gas pipelines for the Advanced Electrolyzer System (“AES”). AES was developed by Pinakin Patel and his team, who have been recipients of significant Federal grant awards for their innovative hydrogen research and development activities. Across the United States and Europe, the ability to store, transport and extract hydrogen […]
August 9, 2021

Clean Technology Industry Veteran, Martin Schuermann, Appointed as Aberdeen’s Executive Chairman of the Board of Directors

Clean technology transportation pioneer, Martin Schuermann, appointed as Executive Chairman of Aberdeen’s Board of Directors Mr. Schuermann to drive refined focus on downstream, transportation and consumer-facing low-carbon strategy With addition of Mr. Schuermann, the Company elevates its governance, deal sourcing and execution capabilities TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB) (F: A8H) (OTC: AABVF) is pleased to announce the appointment of Martin Schuermann as Executive Chairman of the Board of Directors of the Company. Mr. Schuermann has been involved in the clean energy sector since 2009, serving as Chief Executive Officer […]
July 28, 2021

PowerTap Hydrogen Capital Corp. (NEO: MOVE) (FWB:2K6B) (OTC: MOTNF) Acquires 49% of AES-100 Inc. to Accelerate Application of the Advanced Electrolyzer System in Hydrogen Refueling Infrastructure

PowerTap Hydrogen Capital Corp. (PowerTap) acquisition implies ~200% return on Aberdeen’s investment in AES-100 Inc. over an approximate five month period Aberdeen gains strategic partner to accelerate commercialization of the Advanced Electrolyzer System (AES) in global transportation applications PowerTap brings significant technical and financial resources to support commercialization of the AES technology TORONTO, July 28, 2021 (GLOBE NEWSWIRE) — Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB F: A8H, OTC: AABVF) is pleased to inform that PowerTap Hydrogen Capital Corp. (NEO: MOVE) (FWB:2K6B) (OTC: MOTNF) (“PowerTap”) has acquired a 49% ownership stake in Aberdeen investee, AES-100 Inc. AES is […]
July 15, 2021

Aberdeen Acquires Securities in Medivolve

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB) has acquired 24,101,803 units of Medivolve Inc. (“Medivolve”) (NEO: MEDV) in a non-brokered private placement financing of MEDV at a price of $0.07 per unit for a total subscription price of $1,687,126.21. Each unit is comprised of one Medivolve common share and one Medivolve common share purchase warrant. Each common share purchase warrant is exercisable for one common share of Medivolve at a price of $0.08 for a period of five years. Prior to this transaction, Aberdeen did not own Common Shares of MEDIVOLVE. Subsequent to […]